Apellis Pharmaceuticals Inc P/E
What is the P/E of Apellis Pharmaceuticals Inc?
The P/E of Apellis Pharmaceuticals Inc is 0.00
What is the definition of P/E?
Price to earnings ratio is the ratio of a company’s stock price to the company’s earnings per share calculated over trailing twelve months.
= previous day’s close / ttm EPS
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E of companies in the Health Care sector on NASDAQ compared to Apellis Pharmaceuticals Inc
What does Apellis Pharmaceuticals Inc do?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Companies with p/e similar to Apellis Pharmaceuticals Inc
- Richland Resources International has P/E of N/A
- Safeplus International has P/E of N/A
- China Yanyuan Yuhui Natl Ed Grp has P/E of N/A
- Acusphere has P/E of N/A
- American Oriental Bioengineering has P/E of N/A
- Gourmet Provisions International has P/E of N/A
- Apellis Pharmaceuticals Inc has P/E of 0.00
- SEL Manufacturing has P/E of 0.00
- China Zhong Qi Hldgs has P/E of 0.00
- MedSmart has P/E of 0.00
- Panbela Therapeutics has P/E of 0.00
- Epic has P/E of 0.00
- 2574 has P/E of 0.00